African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2284

Full Length Research Paper

Effect of chemotherapy with cisplatin and rapamycin on HeLa cells in vitro

Lu Han1*, Jie-ling Wu2 and Li-xiao Yang3
1Dalian Obstetrics and Gynecology Hospital, Dalian 116033, China. 2Dalian Blood Center, Dalian 116001, China. 3Maternal and Child Health Hospital, Fangshan district, Beijing 102488, China.
Email: [email protected]

  •  Accepted: 24 September 2012
  •  Published: 15 February 2013

Abstract

The aim of this study was to evaluate the effect of combination of rapamycin (RPM) with cisplatin on the proliferation of cervical cancer HeLa cells in vitro, as well as the expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF). HeLa cells were treated with RPM and cisplatin, respectively or through combining them for 72 h. There were four groups in this experiment, namely, RPM, cisplatin, RPM combined with cisplatin, and control group (culture medium only). The expression of mRNA and the protein of genes HIF-1α and VEGF were detected using reverse transcription-polymerase chain reaction (RT-PCR) and western blot respectively. A down-regulation of the mRNA and protein expression of HIF-1α and VEGF was observed in HeLa cells corresponding to the rapamycin group, cisplatin group, and RPM combined with cisplatin group compared with the control group (p < 0.05). The mRNA and protein expression of HIF-1α and VEGF were significantly down-regulated in the combined group. No significant difference was found between the RPM group and cisplatin group (p < 0.05). The mRNA and protein expression of both HIF-1α and VEGF were significantly down-regulated by the combination of RPM with cisplatin

 

Key words: HeLa cells, Rapamycin, cisplatin, hypoxia-inducible factor-1α, vascular endothelial growth factor.